| |
 |
ARTICLES 
|
|
| 2-Chlorodeoxyadenosine: drug development priorities |
| LD Piro |
|
JCO Oct 1 1992: 1507–1510.
[PDF]
|
 |
| Second primary malignancies in small-cell lung cancer: a major consequence of modest success |
| DC Ihde and MA Tucker |
|
JCO Oct 1 1992: 1511–1513.
[PDF]
|
|
|
On the bioavailability of oral and subcutaneous 2-chloro-2'- deoxyadenosine in humans: alternative routes of administration |
| |
J Liliemark, F Albertioni, M Hassan, and G Juliusson |
| |
JCO Oct 1 1992: 1514–1518.
[Abstract]
[PDF]
|
|
|
The incidence of second primary tumors in long-term survivors of small- cell lung cancer |
| |
KH Heyne, SM Lippman, JJ Lee, JS Lee, and WK Hong |
| |
JCO Oct 1 1992: 1519–1524.
[Abstract]
[PDF]
|
|
|
Second primary malignancies following diagnosis of small-cell lung cancer |
| |
U Sagman, M Lishner, E Maki, FA Shepherd, R Haddad, WK Evans, G DeBoer, D Payne, JF Pringle, and JL Yeoh |
| |
JCO Oct 1 1992: 1525–1533.
[Abstract]
[PDF]
|
|
|
Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis |
| |
IJ Diel, M Kaufmann, R Goerner, SD Costa, S Kaul, and G Bastert |
| |
JCO Oct 1 1992: 1534–1539.
[Abstract]
[PDF]
|
|
|
Adjuvant therapy with escalating doses of doxorubicin and cyclophosphamide with or without leukocyte alpha-interferon for stage II or III breast cancer |
| |
AU Buzdar, GN Hortobagyi, SW Kau, TL Smith, G Fraschini, FA Holmes, JU Gutterman, VM Hug, SE Singletary, and FC Ames |
| |
JCO Oct 1 1992: 1540–1546.
[Abstract]
[PDF]
|
|
|
Adjuvant aminoglutethimide for postmenopausal patients with primary breast cancer: analysis at 8 years |
| |
AL Jones, TJ Powles, M Law, A Tidy, D Easton, RC Coombes, IE Smith, JA McKinna, A Nash, and HT Ford |
| |
JCO Oct 1 1992: 1547–1552.
[Abstract]
[PDF]
|
|
|
Improved palliation of cerebral metastases in epithelial ovarian cancer using a combined modality approach including radiation therapy, chemotherapy, and surgery |
| |
GC Rodriguez, JT Soper, A Berchuck, J Oleson, R Dodge, G Montana, and DL Clarke- Pearson |
| |
JCO Oct 1 1992: 1553–1560.
[Abstract]
[PDF]
|
|
|
Ten-year outcome of patients with advanced epithelial ovarian carcinoma treated with cisplatin-based multimodality therapy |
| |
PJ Hoskins, SE O'Reilly, KD Swenerton, JJ Spinelli, RN Fairey, and JL Benedet |
| |
JCO Oct 1 1992: 1561–1568.
[Abstract]
[PDF]
|
|
|
High-dose busulfan in patients with myeloma |
| |
J Mansi, F da Costa, C Viner, I Judson, M Gore, and D Cunningham |
| |
JCO Oct 1 1992: 1569–1573.
[Abstract]
[PDF]
|
|
|
Phase II trial of cisplatin and alpha-interferon in advanced malignant melanoma |
| |
KA Margolin, JH Doroshow, SA Akman, LA Leong, RJ Morgan, G Somlo, J Raschko, C Pereira, L Yonemoto, and C Ahn |
| |
JCO Oct 1 1992: 1574–1578.
[Abstract]
[PDF]
|
|
|
A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup |
| |
VH Bramwell, M Burgers, R Sneath, R Souhami, AT van Oosterom, PA Voute, J Rouesse, D Spooner, AW Craft, and R Somers |
| |
JCO Oct 1 1992: 1579–1591.
[Abstract]
[PDF]
|
|
|
Etoposide and carboplatin in neuroblastoma: a French Society of Pediatric Oncology phase II study |
| |
D Frappaz, J Michon, O Hartmann, E Bouffet, O Lejars, H Rubie, JC Gentet, P Chastagner, E Sariban, and L Brugiere |
| |
JCO Oct 1 1992: 1592–1601.
[Abstract]
[PDF]
|
|
|
Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric Oncology |
| |
O Oberlin, G Leverger, H Pacquement, MA Raquin, A Chompret, JL Habrand, MJ Terrier-Lacombe, P Bey, Y Bertrand, and H Rubie |
| |
JCO Oct 1 1992: 1602–1608.
[Abstract]
[PDF]
|
|
|
Fasting plasma lipid measurements following cisplatin chemotherapy in patients with germ cell tumors |
| |
PA Ellis, BM Fitzharris, PM George, BA Robinson, CH Atkinson, and BM Colls |
| |
JCO Oct 1 1992: 1609–1614.
[Abstract]
[PDF]
|
|
|
Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimen |
| |
A Bosly, B Coiffier, C Gisselbrecht, H Tilly, G Auzanneau, F Andrien, R Herbrecht, M Legros, Y Devaux, and J Jaubert |
| |
JCO Oct 1 1992: 1615–1623.
[Abstract]
[PDF]
|
|
|
Phase I trial of etoposide with cyclosporine as a modulator of multidrug resistance |
| |
AM Yahanda, KM Alder, GA Fisher, NA Brophy, J Halsey, RI Hardy, MP Gosland, BL Lum, and BI Sikic |
| |
JCO Oct 1 1992: 1624–1634.
[Abstract]
[PDF]
|
|
|
Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance |
| |
BL Lum, S Kaubisch, AM Yahanda, KM Adler, L Jew, MN Ehsan, NA Brophy, J Halsey, MP Gosland, and BI Sikic |
| |
JCO Oct 1 1992: 1635–1642.
[Abstract]
[PDF]
|
|
|
Intravenous administration of recombinant human macrophage colony- stimulating factor to patients with metastatic cancer: a phase I study |
| |
MG Sanda, JC Yang, SL Topalian, ES Groves, A Childs, R Belfort, Jr, MD de Smet, DJ Schwartzentruber, DE White, and MT Lotze |
| |
JCO Oct 1 1992: 1643–1649.
[Abstract]
[PDF]
|
|
| AIDS and non-Hodgkin's lymphoma: a pre-pre-B-cell monoclonal lymphoma versus a novel mechanism of polyclonality? |
| M Seiden and J Sklar |
|
JCO Oct 1 1992: 1650–1651.
[PDF]
|
|
| Smoking in young men with testicular cancer |
| DM Waterhouse |
|
JCO Oct 1 1992: 1651–1652.
[PDF]
|
|
| Increased incidence of cardiovascular risk factors in cured testicular cancer patients |
| JA Gietema, EG de Vries, and DT Sleijfer |
|
JCO Oct 1 1992: 1652a.
[PDF]
|
|
| Review of autologous bone marrow transplantation for metastatic breast cancer: a minor point? |
| G Ellis |
|
JCO Oct 1 1992: 1652b–1653.
[PDF]
|
|
| High-dose chemotherapy with ABMT for metastatic breast cancer |
| M Martin |
|
JCO Oct 1 1992: 1653–1654.
[PDF]
|
|
